Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Stanovení nikotinové kyseliny a jejích metabolitů pomocí HPLC-MS/MS
[Analysis of nicotinic acid and its metabolites by HPLC-MS/MS]

K. Žantová, E. Tvrzická, M. Vecka, A. Žák

. 2015 ; 109 (12) : 950-956.

Language Czech Country Czech Republic

Document type Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16008260

Nicotinic acid is a hypolipidemic agent with pleiotropic effects. Its drug form with controlled release leads to pyridine metabolites associated with the risk of hepatotoxicity. The aim of the present study was to introduce a HPLC-MS method for the determination of nicotinic acid, nicotinamide, nicotinuric acid, N-methylnicotin¬amide, nicotinamide 1-oxide, 1-methyl-2-oxo-1,2-dihydro¬pyridine-5-carboxamide, and 1-methyl-4-oxo-1,4-dihydro¬pyridine-5-carboxamide in blood plasma or urine. The method is useful for the monitoring in hypolipidemic the¬rapy. We have compared calibration curves of individual metabolites using Hypercarb (graphite carbon) and Hypersil Silica (silicagel) columns. Both columns gave linear calibration curves for all the mentioned analytes (except for 1-methylnicotinamide) in the concentration range 10–2000 ng ml–1. The calibration curve in blood plasma and urine measured with the Hypersil Silica column was linear in the range 20–4000 ng ml–1 for all the tested analytes. The analysis time was 15 min with the column Hypercarb and 27 min with Hypersil Silica. Biological samples were extracted with sulfonated copolymer N-vinylpyrrolidone – divinylbenzene. Reproducibility of the results for biological samples varied between 0.06 % and 19.97 %.

Analysis of nicotinic acid and its metabolites by HPLC-MS/MS

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc16008260
003      
CZ-PrNML
005      
20160412133058.0
007      
ta
008      
160320s2015 xr d f 000 0|cze||
009      
AR
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Žantová, Kamila $7 xx0206726 $u Univerzita Karlova v Praze, 1. lékařská fakulta, 4. interní klinika, U Nemocnice 2, Praha 2
245    10
$a Stanovení nikotinové kyseliny a jejích metabolitů pomocí HPLC-MS/MS / $c K. Žantová, E. Tvrzická, M. Vecka, A. Žák
246    31
$a Analysis of nicotinic acid and its metabolites by HPLC-MS/MS
504    __
$a Literatura
520    9_
$a Nicotinic acid is a hypolipidemic agent with pleiotropic effects. Its drug form with controlled release leads to pyridine metabolites associated with the risk of hepatotoxicity. The aim of the present study was to introduce a HPLC-MS method for the determination of nicotinic acid, nicotinamide, nicotinuric acid, N-methylnicotin¬amide, nicotinamide 1-oxide, 1-methyl-2-oxo-1,2-dihydro¬pyridine-5-carboxamide, and 1-methyl-4-oxo-1,4-dihydro¬pyridine-5-carboxamide in blood plasma or urine. The method is useful for the monitoring in hypolipidemic the¬rapy. We have compared calibration curves of individual metabolites using Hypercarb (graphite carbon) and Hypersil Silica (silicagel) columns. Both columns gave linear calibration curves for all the mentioned analytes (except for 1-methylnicotinamide) in the concentration range 10–2000 ng ml–1. The calibration curve in blood plasma and urine measured with the Hypersil Silica column was linear in the range 20–4000 ng ml–1 for all the tested analytes. The analysis time was 15 min with the column Hypercarb and 27 min with Hypersil Silica. Biological samples were extracted with sulfonated copolymer N-vinylpyrrolidone – divinylbenzene. Reproducibility of the results for biological samples varied between 0.06 % and 19.97 %.
650    12
$a chemické techniky analytické $7 D002623
650    _2
$a niacin $x analýza $x farmakokinetika $x metabolismus $x škodlivé účinky $7 D009525
650    _2
$a metody pro přípravu analytických vzorků $7 D053000
650    12
$a vysokoúčinná kapalinová chromatografie $x metody $x přístrojové vybavení $x využití $7 D002851
650    12
$a tandemová hmotnostní spektrometrie $x metody $x přístrojové vybavení $x využití $7 D053719
650    12
$a kyseliny nikotinové $x analýza $x farmakokinetika $x metabolismus $x škodlivé účinky $7 D009539
650    _2
$a krevní plazma $7 D010949
650    _2
$a zdraví dobrovolníci pro lékařské studie $7 D064368
650    _2
$a lidé $7 D006801
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tvrzická, Eva $7 xx0076496 $u Univerzita Karlova v Praze, 1. lékařská fakulta, 4. interní klinika, U Nemocnice 2, Praha 2
700    1_
$a Vecka, Marek, $d 1976- $7 xx0076497 $u Univerzita Karlova v Praze, 1. lékařská fakulta, 4. interní klinika, U Nemocnice 2, Praha 2
700    1_
$a Žák, Aleš, $d 1951- $7 mzk2007382175 $u Univerzita Karlova v Praze, 1. lékařská fakulta, 4. interní klinika, U Nemocnice 2, Praha 2
773    0_
$t Chemické listy $x 0009-2770 $g Roč. 109, č. 12 (2015), s. 950-956 $w MED00011010
856    41
$u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/279/279 $y domovská stránka časopisu
910    __
$a ABA008 $b B 1918 $c 395 $y 4 $z 0
990    __
$a 20160320160514 $b ABA008
991    __
$a 20160412133142 $b ABA008
999    __
$a ok $b bmc $g 1111486 $s 932601
BAS    __
$a 3
BMC    __
$a 2015 $b 109 $c 12 $d 950-956 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010
LZP    __
$c NLK137 $d 20160412 $a NLK 2016-13/dk

Find record

Citation metrics

Archiving options